Allodynia: When Touch That Should Not Hurt Does

There is a particular experience that many people with fibromyalgia describe and struggle to explain to others: a light touch on the arm that sends a sharp wave of pain, a waistband that feels like it is cutting into the skin, a bedsheet that the legs cannot tolerate. These are not exaggerations or signs of psychological fragility. They are manifestations of allodynia, a well-characterized neurological phenomenon with a specific mechanism [5].

The International Association for the Study of Pain defines allodynia as “pain due to a stimulus that does not normally provoke pain” [5]. The key word is “normally.” The stimulus itself, a light brush across the skin, a gentle squeeze, a temperature change, activates receptors that do not signal pain in a healthy nervous system. In allodynia, the nervous system converts these non-painful signals into pain. The problem is not in the stimulus or in the tissue; it is in the processing.

Understanding allodynia matters for two reasons beyond intellectual curiosity. First, it provides a mechanistic explanation for symptoms that are otherwise dismissed as exaggeration, giving patients a framework for communicating what is happening to them. Second, the mechanism points toward the treatment target: allodynia is driven by central sensitization, and interventions that reduce central sensitization (medication, exercise, sleep improvement, stress management) are the same interventions that can reduce allodynia. The symptom and the mechanism are informative about each other.

The Mechanism

To understand allodynia, it helps to distinguish two types of nerve fibers. A-beta fibers are large, myelinated fibers that carry touch and pressure signals. They respond to light mechanical stimuli: the feel of clothing, the brush of a hand, the pressure of sitting. In a normal nervous system, these signals are processed as touch, not pain. C-fibers are small, unmyelinated fibers that carry pain signals. They respond to tissue-damaging stimuli: cuts, burns, strong impacts [1].

In central sensitization, spinal cord neurons become hyperexcitable. They undergo changes in which the threshold for activation drops and the receptive field expands. Critically, they begin responding to A-beta fiber input as though it were C-fiber input. Touch signals arrive at the spinal cord and are processed as pain signals [2].

Woolf described this as a phenotypic switch: the dorsal horn neuron has not changed its connections but has changed what it does with the signals it receives. The same neuron that previously processed A-beta input as touch now processes it as pain. The wiring is unchanged; the gain is turned up [1].

The molecular mechanisms underlying this switch involve several processes. At the synapse, repeated nociceptive input causes increased release of glutamate and substance P from C-fiber terminals. Glutamate activates NMDA receptors on dorsal horn neurons, leading to calcium influx that triggers intracellular signaling cascades. These cascades increase the density of AMPA receptors on the postsynaptic membrane, lower the threshold for neuronal firing, and expand the receptive field of the neuron so that it begins responding to inputs from adjacent A-beta fibers that it previously ignored [2]. The result is a dorsal horn neuron that fires in response to touch and sends that signal up the spinothalamic tract coded as pain.

Gracely and colleagues demonstrated the functional consequence of this with fMRI. When they applied mild pressure to people with fibromyalgia, the brain activation patterns matched those of controls receiving much stronger pressure [4]. The fibromyalgia brain was not imagining pain; it was producing a neural response to mild stimuli that matched the control brain’s response to genuinely painful stimuli. The amplification was real, measurable, and occurring at the level of central processing.

Types of Allodynia in Fibromyalgia

Allodynia in fibromyalgia commonly presents in several forms [3]:

Tactile allodynia: Pain from light touch or pressure that would normally be perceived as neutral or pleasant. Clothing against the skin, a hand on the shoulder, the pressure of sitting. This is often the most disruptive form in daily life because it makes normal activities, wearing certain fabrics, being touched by a partner, sitting for extended periods, sources of pain rather than unremarkable sensations.

Mechanical allodynia: Pain from stimuli involving movement across the skin, such as brushing or stroking. Toweling dry after a shower or having someone lightly rub the back. The distinction from tactile allodynia is that the stimulus involves dynamic rather than static touch, which activates slightly different populations of mechanoreceptors.

Thermal allodynia: Pain from mild temperature changes that would not normally be painful. A slightly cool breeze or lukewarm water perceived as burning. Thermal allodynia involves the temperature-sensing fibers (A-delta and C-fibers that respond to warmth and cold), and its presence suggests that the hyperexcitability in the dorsal horn extends beyond mechanoreceptive inputs to thermoreceptive ones.

Not everyone with fibromyalgia experiences allodynia to the same degree. It can fluctuate with overall symptom severity, worsening during flares and improving during periods of lower symptom activity. This variability is consistent with the dynamic nature of central sensitization: the degree of spinal cord hyperexcitability changes with sleep, stress, activity, and other modulating factors. A poor night of sleep that increases sensitization may produce a day when clothing feels unbearable; several good nights in a row may bring it back to tolerable. The allodynia is tracking the underlying sensitization state, not the state of the skin or the pressure of the fabric.

The Dismissal Problem

Allodynia creates a specific communication challenge. When a person says that light touch hurts, others who have not experienced it may interpret this as psychological hypersensitivity, attention-seeking, or exaggeration. The response is often implicit or explicit dismissal: it cannot really hurt that much, or the pain must be amplified by anxiety.

This dismissal has been directed at fibromyalgia patients by clinicians as well as by family members and colleagues. The history of fibromyalgia as a diagnosis includes a period during which the condition was widely regarded as psychosomatic, and allodynia, because it seems so implausible to a person with normal pain processing, became one of the symptoms most likely to be doubted [6].

The mechanistic understanding corrects this. Allodynia is produced by a measurable change in spinal cord neuron behavior. The A-beta fibers are functioning normally; they are sending accurate touch signals. The dorsal horn neurons are receiving those signals and producing pain responses because their excitability threshold has shifted. This is no more voluntary or psychological than the pain from a burn. The mechanism is different, but the pain is equally real.

Knowing this mechanism changes the conversation. A patient who can explain that their pain is produced by a well-documented change in spinal cord processing, described in the peer-reviewed literature and demonstrated with functional imaging, is in a stronger position to be taken seriously than one who can only say “light touch hurts me.” The explanation does not make the pain less frustrating, but it makes the dismissal less tenable.

What Can Help

Because allodynia is driven by central sensitization, the treatments that address it are the same treatments that address fibromyalgia more broadly. Medications that modulate central sensitization, particularly pregabalin and duloxetine, may reduce allodynia along with other pain symptoms [6]. Exercise, which over time can improve descending inhibitory function and reduce overall sensitization, may reduce allodynia severity. Sleep improvement is relevant because poor sleep is one of the most reliable triggers for increased sensitization and, by extension, worsened allodynia. Stress management matters because psychological stress activates the same neurobiological systems that amplify pain processing.

There is no treatment that specifically targets allodynia in isolation. This is consistent with the understanding that allodynia is a manifestation of the broader sensitization state rather than a separate problem requiring a separate solution. Reducing the sensitization reduces the allodynia.

What Remains Uncertain

Whether allodynia in fibromyalgia is primarily maintained by ongoing peripheral input (small fiber activity from muscles and skin) or can become self-sustaining through central mechanisms alone is debated. Some evidence suggests that small fiber neuropathy, which affects a subset of fibromyalgia patients, may provide the ongoing peripheral input that maintains central sensitization and allodynia. If so, treatments targeting peripheral nerve function might reduce allodynia in that subgroup, but this remains investigational.

The relationship between allodynia severity and treatment response is also not well characterized. It is plausible that patients with more pronounced allodynia have a different balance of peripheral and central mechanisms than those with less, and that this difference would predict which treatments help, but the trials have not consistently measured allodynia as a separate outcome variable. Most fibromyalgia trials use composite pain measures that do not isolate allodynia from other pain types, which limits what we can say about allodynia-specific treatment effects.

Quantitative sensory testing can measure allodynia thresholds, but whether these measurements are useful for tracking treatment response in individual patients is not established. Whether specific treatments target allodynia more effectively than they target other fibromyalgia symptoms is unclear: most trials report overall pain scores rather than separating allodynia from spontaneous pain. And whether the presence and severity of allodynia identifies a particular subgroup of fibromyalgia patients who might respond to different treatments is a question that subgroup analyses have not adequately addressed. The clinical observation that allodynia severity varies considerably between fibromyalgia patients suggests that it may reflect different degrees or possibly different types of central sensitization, but the research to distinguish these has not been done.

Getting support for chronic pain. Chronic pain, including fibromyalgia, is a complex medical condition that deserves proper clinical attention. A GP, rheumatologist or pain specialist can help develop a management plan. The American Chronic Pain Association (theacpa.org) and the National Fibromyalgia Association (fmaware.org) have patient resources and practitioner directories.